Bellerophon Therapeutics, Inc. Annual Weighted Average Number of Shares Outstanding, Basic from 2016 to 2022

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Bellerophon Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from 2016 to 2022.
  • Bellerophon Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 12.2M shares, a 28.2% increase year-over-year.
  • Bellerophon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 9.55M shares, a 0.51% increase from 2021.
  • Bellerophon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 9.5M shares, a 21.9% increase from 2020.
  • Bellerophon Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2020 was 7.8M shares, a 73.1% increase from 2019.
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 9.55M +48.1K +0.51% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 9.5M +1.71M +21.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 7.8M +3.29M +73.1% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-31
2019 4.5M +674K +17.6% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-31
2018 3.83M +1.23M +47.5% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 2.6M -12.5M -82.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-04-06
2016 15.1M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.